CS Paper Radar

Lesion-Gated Hybrid Synthesis for Virtual Contrast-Enhanced Breast MRI: A MAMA-SYNTH Challenge Solution

Shohei Yoshimoto

eess.IV cs.CV ·submitted 2026-09-18 09:53 UTC · v1
benchmark

Abstract

Purpose: Contrast-enhanced breast MRI depends on intravenous gadolinium-based contrast agents, motivating methods that synthesise post-contrast appearance from pre-contrast images alone. The MAMA-SYNTH Challenge (MICCAI 2026 Deep-Breath Workshop) evaluates such synthesis across four metric groups: image fidelity, tumour region of interest, downstream classification, and downstream segmentation. The four group ranks are averaged, so optimising a single objective is insufficient. Materials and Methods: We developed a lesion-gated hybrid synthesis pipeline. A lesion probability map, estimated from the pre-contrast slice alone by an ensemble of pre-contrast-only segmentation networks, spatially coordinates a tumour-focused regression pathway and a background-focused Pix2PixHD synthesis pathway, followed by a region-dependent calibration of the predicted enhancement. Training used the public MAMA-MIA collection with a patient-level split. Inference consumes a single pre-contrast 2D slice, with no mask, no post-contrast image, and no auxiliary metadata beyond image geometry. Results: On internal validation (n = 120 patients) the method reached MSE 0.523, LPIPS 0.185, and tumour-region SSIM 0.495. It was submitted to the hidden external 300-case test cohort as a self-contained inference container. The method ranked sixth in the official MAMA-SYNTH Challenge leaderboard. Conclusion: A test-compatible lesion probability map derived from the pre-contrast image can coordinate complementary tumour-focused regression and background-focused perceptual synthesis, enabling balanced virtual contrast enhancement under a multi-metric challenge setting.

Comment
8 pages, 2 figures, 3 tables. MAMA-SYNTH Challenge solution report; the submitted method ranked 6th in the official challenge leaderboard

Closest papers

Nearest neighbours by meaning across the whole index.

Anatomy-Aware Synthesis of Post-Contrast Breast MRI from Pre-Contrast Images

cs.CV ·2026-09-22 ·Zhengbo Zhou, Dooman Arefan, Lin Gu, Ufara Zuwasti Curran, Shandong Wu
similarity 0.81
Abstract

We developed an anatomy-aware deep learning framework to synthesize post-contrast breast MRI from pre-contrast images, emphasizing tumor and background parenchymal enhancement (BPE) regions. This retrospective study included 649 patients with 6,251 paired pre-contrast and post-contrast images. The framework integrates breast mask consistency, lesion-region supervision, and BPE-region supervision into an image-to-image translation model. Evaluation included quantitative image quality metrics, a reader study with two breast radiologists, and downstream Ki-67 classification. The proposed method outperformed Pix2Pix, Pix2PixHD, diffusion-based synthesis, and mask-supervised baselines in whole-image and regional evaluations. Ki-67 classification showed no statistically significant performance differences across real- and synthetic-image training and testing settings, although this does not establish equivalence. These findings suggest that anatomy-aware supervision improves synthesis fidelity and support further investigation of synthetic post-contrast MRI for contrast-free imaging workflows.

0.13

Anguinus Sculpturae: Compositional Synthesis of Peak-Enhancement Breast DCE-MRI Scans

cs.CV ·2026-09-27 ·Benjamin Hamm, Nico Albert Disch, Maximilian Rokuss, Yannick Kirchhoff, Constantin Ulrich +1 more
publishedcode/data similarity 0.80
Abstract · Accepted as an oral at the MAMA-SYNTH 2026 challenge / Deep-BreAth 2026 Workshop, MICCAI 2026. 12 pages, 3 figures, 1 table

Dynamic contrast-enhanced breast MRI (DCE-MRI) is rich in anatomical and perfusion information, but its reliance on gadolinium-based contrast agents raises safety concerns and adds cost. Virtual contrast enhancement, synthesizing post-contrast from pre-contrast images, is a promising alternative. We address the MAMA-SYNTH challenge task of predicting peak-enhancement breast MRI. Rather than adopting the full machinery of diffusion or flow matching, we observe that under a rectified, straight-line path the generative process collapses to a single difference prediction: the synthetic peak image is the pre-contrast image plus a predicted enhancement map, recovered in one forward pass. Around this we build Anguinus Sculpturae, a compositional pipeline in which nnU-Net segmentations of lesion, foreground and breast region guide two generators - one optimized for global fidelity, one for lesion structure through an asymmetric Tversky term routed via a frozen segmenter - composited region-wise with Gaussian-weighted blending. On the held-out Duke subset of MAMA-MIA our model achieves the best FRD and Dice among all evaluated variants, showing that single-step difference prediction with segmentation guidance suffices to recover both global fidelity and lesion structure. Code is available at https://github.com/MIC-DKFZ/AnguinusSculpturae.

0.31

MAMA-FLUX.2: Image-to-Image Synthesis of Post-Contrast Breast DCE-MRI for the MAMA-SYNTH Challenge

cs.CV ·2026-08-26 ·Kamil Kwarciak, Marek Wodzinski
similarity 0.75
Abstract · 9 pages, 3 figures, 1 table

Dynamic contrast-enhanced breast MRI is central to cancer diagnosis and monitoring, but requires gadolinium-based contrast agents. In this work, we address pre-to-post contrast breast MRI synthesis for the MAMA-SYNTH challenge. We propose MAMA-FLUX.2, a conditional latent flow-matching approach based on FLUX.2-Klein-4B. The pre-contrast image is encoded as spatial conditioning, while the model predicts the flow field associated with the post-contrast target latent. To adapt the pretrained model efficiently, we use LoRA fine-tuning and introduce a regional training objective combining global flow matching, tumor-region supervision, and stable foreground regularization. We further investigate LoRA rank, intensity windowing, and regional loss weights on axial slices, prioritizing clinically relevant tumor-focused metrics. Our ablation study shows that moderate tumor and stable-foreground weighting improves the trade-off between image fidelity and tumor-region accuracy. The final model achieves the best overall balance with LoRA rank/$α=64/64$, $\mathrm{MHA}_{\max}=25$, $λ_{\mathrm{tumor}}=0.25$, and $λ_{\mathrm{stable}}=0.1$. These results demonstrate that compact pretrained rectified-flow transformers can be adapted for contrast-enhanced MRI synthesis using parameter-efficient fine-tuning and task-aware regional losses.

0.29

Toward Contrast-Free Breast MRI: Improving Cancer Detection With Virtual Contrast Enhanced Imaging

eess.IV cs.CV ·2026-10-29 ·Hongxi Chen, Sunwoo Kwak, Sanyukta Adap, Katerina Dodelzon, Paula Feldman +1 more
similarity 0.70
Abstract · 5 pages, 2 figures, 1 table. Submitted to ISBI 2027

Although contrast-enhanced (CE) breast MRI is an important tool for cancer detection, intravenous gadolinium administration introduces additional considerations for patients and clinical workflows. AI based virtual contrast enhanced (VCE) MRI could help identify patients for whom acquired CE imaging may be avoidable without compromising diagnostic performance. We developed a framework that combines non contrast (NC) and VCE MRI predictions for cancer detection. On the held-out test set, cancer detection using NC MRI alone achieved an AUROC of 0.865. Combining the predictions from NC and VCE MRI improved AUROC to 0.901. Building on this complementary predictive value, we evaluated patient-level routing to progressively replace acquired CE examinations with the NC plus VCE pathway, prioritizing patients with the most confident NC predictions. This simulation suggests that diagnostic performance can be largely preserved while limiting acquired CE imaging to approximately 40% of patients. Together, these findings demonstrate the complementary value of VCE MRI and suggest its potential to support selective contrast use in breast cancer screening.

0.22

CAPS: Clinically-Verifiable Anatomy-Prioritized Synthesis for Missing MRI Imputation in Brain Tumor Segmentation

eess.IV cs.CV ·2026-10-20 ·Cecilia Diana-Albelda, Arthur Longuefosse, Mario Rubén Paz Campos, Álvaro García-Martín, Jesus Bescos
similarity 0.69
Abstract · 20 pages, 6 figures, 8 tables. Cecilia Diana-Albelda and Arthur Longuefosse contributed equally

Multi-parametric MRI is the gold standard for neuro-oncology, yet acquiring complete 4-modality protocols may be unfeasible in real-world clinical practice. When handling missing modalities, existing automated systems force a critical compromise: robust segmenters operate as uninterpretable "black boxes" that bypass image generation, while standard synthesis models often produce blurry reconstructions lacking diagnostic reliability. To address this issue, we propose CAPS, a Clinically-Verifiable Anatomy-Prioritized Synthesis framework that reconciles computational precision with clinical transparency. Our multi-modal generative architecture is driven by a hybrid objective function (L_1 + L_AFP + L_DualDice) that explicitly enforces the preservation of deep anatomical features and strict topological boundaries, rather than relying solely on pixel-wise optimization. Evaluated comprehensively on the BraTS Adult Glioma dataset, the framework achieves superior synthesis fidelity across intensity-based metrics, and demonstrates robust downstream segmentation performance (82.38% mean Dice), successfully restoring verifiable visual context. Furthermore, the framework exhibits exceptional zero-shot cross-domain generalization, maintaining high structural fidelity across completely unseen Meningioma, Pediatric, and Sub-Saharan African cohorts without domain-specific adaptation. Finally, a blinded radiological assessment confirms that our anatomy-aware approach significantly enhances both perceived image quality and clinical utility, providing clinicians with the reliable visual evidence required to trust downstream automated workflows.

0.20

Mixture of Multi-Sequence Feature Difference for Contrast-Enhanced MRI Synthesis

cs.CV ·2026-10-15 ·Jonghun Kim, Junmo Kwon, Hyunjin Park
similarity 0.68
Abstract · ACCV 2026

Contrast-enhanced magnetic resonance imaging (CE-MRI) is crucial for accurately diagnosing and segmenting brain tumors. However, the acquisition of CE-MRI requires injecting contrast agents, which poses potential health risks and increases scan costs. Here, we propose a CE-MRI synthesis method from non-contrast sequences, reducing both risk and cost. Unlike existing methods that rely on channel-wise concatenation to fuse multi-sequence information for synthesis, we introduce a Mixture of Feature Difference (MoFD) module. The proposed module uses a dynamic weighting strategy to adaptively select and aggregate informative features from both individual source sequences and explicit differences among them. Quantitative and qualitative evaluations demonstrate that our proposed method outperforms baselines in terms of image fidelity and perceptual quality on the UCSF-PDGM and UPenn-GBM datasets. Our method successfully reconstructs tumor regions and achieves segmentation performance comparable to that obtained with real CE-MRI. Our ablation studies show that although adversarial learning improves perceptual quality, a regression-based variant of our method achieves higher structural fidelity.

0.24

Diffusion-Based Synthesis of Complete 3D Biparametric Prostate MRI

cs.CV ·2026-10-22 ·Claudia Giardina, Montse Pardàs, Verónica Vilaplana
publishedhot direction similarity 0.65
Abstract · Presented at the 6th Deep Generative Models Workshop (DGM4MICCAI), MICCAI 2026

Synthetic biparametric MRI (bpMRI) may help alleviate the limited availability of large and representative prostate MRI datasets for deep learning applications. In this work, we present a conditional 3D diffusion framework for anatomy-conditioned synthesis of complete prostate bpMRI from anatomical masks. The framework supports sequential synthesis, in which T2w and diffusion modalities are generated by separately trained models, and joint synthesis, in which all bpMRI modalities are generated simultaneously within a single model. Five configurations were trained using PI-CAI, FastMRI Prostate, and PROSTATEx datasets to investigate different conditioning schemes, target modalities, and synthesis strategies. Evaluation using distribution-based metrics, paired-image similarity, and qualitative assessment demonstrated the feasibility of both synthesis pathways. Joint synthesis achieved competitive distributional fidelity while generating complete bpMRI, whereas direct synthesis of ADC and computed high-b-value DWI outperformed their derivation from synthetic diffusion-weighted images.

0.34

Subtraction-Based Tumor Segmentation and Lesion-Centered pCR Prediction for the MAMA-MIA Challenge

cs.CV cs.AIcs.LG ·2026-08-29 ·Kai Geissler, Raphael Schäfer
code/data similarity 0.64
Abstract

We describe the submission of team FME to the MAMA-MIA Challenge, which evaluated primary tumor segmentation and prediction of pathological complete response (pCR) from pretreatment dynamic contrast-enhanced breast MRI on an external multi-country cohort. For segmentation, we trained a five-fold residual-encoder nnU-Net ensemble using only the first post-contrast minus pre-contrast image, combined with mirroring test-time augmentation and largest-connected-component filtering. For pCR prediction, we ensembled 25 pretrained 3D video classifiers trained on lesion-centred crops from the pre-contrast and first two post-contrast volumes. FME ranked second in both tasks. The segmentation method achieved a combined performance-fairness score of 0.882, with Dice 0.713 and normalized Hausdorff distance 0.099. The pCR method achieved a combined score of 0.664, balanced accuracy of 0.541, and equalized-odds disparity of 0.212. The results indicate that subtraction-based input and ensembling support robust tumor segmentation under cross-site domain shift, whereas pCR prediction from baseline DCE-MRI alone remains limited. For the submission repository, see https://github.com/FraunhoferMEVIS/MAMA-MIA-Challenge-FME

0.35